Skip to main navigation
Skip to search
Skip to main content
Western Sydney University Home
Research Profiles Login
Link opens in a new tab
Search content at Western Sydney University
Home
Profiles
Research outputs
Projects
Datasets
HDR theses
Activities
Press/Media
Prizes
Subjects
Research units
Dupilumab in the treatment of asthma
Alice Grey
,
Constance H. Katelaris
Western Sydney University
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
20
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dupilumab in the treatment of asthma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Treatment of Asthma
100%
Dupilumab
100%
Clinical Trial
33%
Randomized Controlled Trial
33%
Asthma
33%
Atopic Dermatitis
33%
Atopy
33%
Glucocorticoid
33%
Interleukin 4
33%
Asthma Exacerbation
33%
Severe Asthma
33%
Interleukin 13
33%
Immunoglobulin G4
33%
Asthma in Adults
33%
Oral
33%
Patient-Reported Outcome
33%
Inflammation
33%
Asthma in Adolescents
33%
T Helper 2 Cell
33%
Immunology and Microbiology
Asthma
100%
Dupilumab
100%
Atopic Dermatitis
33%
Interleukin 4
33%
Interleukin 13
33%
Glucocorticoid
33%
Severe Asthma
33%
Atopy
33%
T Helper 2 Cell
33%
Asthma in Adults
33%
Asthma in Adolescents
33%
Asthma Exacerbation
33%
Immunoglobulin G4
33%
Inflammation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Dupilumab
100%
Inflammation
25%
Randomized Controlled Trial
25%
Clinical Trial
25%
Atopic Dermatitis
25%
Glucocorticoid
25%
Interleukin 4
25%
Interleukin 13
25%
Atopy
25%
Immunoglobulin G4
25%